u/One-Dingo1220 · 102d ago2 prior · awaiting results
$MDCX(Medicus Pharma — $22M non-dilutive financing secured, multiple clinical catalysts ahead on a sub $1 biotech
Medicus Pharma secured $22M non-dilutive debt financing with multiple clinical catalysts ahead: SkinJect Phase 2 data shows promising efficacy in BCC with no serious safety issues, Phase 2b registrational trial underway for Gorlin Syndrome, and pursuit of Orphan Drug Designation and Rare Pediatric Disease voucher could accelerate regulatory pathway. Teverelix advancing in prostate cancer positions company for multi-billion-dollar market opportunity.